Clinical trials on India's first mRNA Covid-19 vaccine to begin soon

Gennova's Covid vaccine candidate HGCO19 would remain stable at 2 to 8 degree Celsius temperature

Emcure Group firm Gennova Biopharmaceuticals, which is developing India’s first mRNA-based Covid-19 vaccine, is set to start recruitment for phase 1 clinical trials in a week.
 
Vikas Thapar, president — corporate development & strategy — Emcure Group, told Business Standard that the firm was readying for clinical trials anytime now. “We got the final nod from the regulator last week to start phase 1 clinical trials. We are going to start it anytime now. The recruitment will begin next week. Phase 1 would be on about 150 people,” Thapar said.
 
As for manufacturing, he said Emcure had sterile